SG10201607710UA - Combined chemical and genetic approaches for generation of induced pluripotent stem cells - Google Patents
Combined chemical and genetic approaches for generation of induced pluripotent stem cellsInfo
- Publication number
- SG10201607710UA SG10201607710UA SG10201607710UA SG10201607710UA SG10201607710UA SG 10201607710U A SG10201607710U A SG 10201607710UA SG 10201607710U A SG10201607710U A SG 10201607710UA SG 10201607710U A SG10201607710U A SG 10201607710UA SG 10201607710U A SG10201607710U A SG 10201607710UA
- Authority
- SG
- Singapore
- Prior art keywords
- generation
- stem cells
- pluripotent stem
- induced pluripotent
- genetic approaches
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/065—Modulators of histone acetylation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/603—Oct-3/4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/604—Klf-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/605—Nanog
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/608—Lin28
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/08—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/09—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from epidermal cells, from skin cells, from oral mucosa cells
- C12N2506/094—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from epidermal cells, from skin cells, from oral mucosa cells from keratinocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/28—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from vascular endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6995608P | 2008-03-17 | 2008-03-17 | |
US19798608P | 2008-10-31 | 2008-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201607710UA true SG10201607710UA (en) | 2016-11-29 |
Family
ID=41091504
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2013019211A SG188904A1 (en) | 2008-03-17 | 2009-03-17 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
SG10201607710UA SG10201607710UA (en) | 2008-03-17 | 2009-03-17 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
SG10202103401QA SG10202103401QA (en) | 2008-03-17 | 2009-03-17 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
SG10201808863UA SG10201808863UA (en) | 2008-03-17 | 2009-03-17 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2013019211A SG188904A1 (en) | 2008-03-17 | 2009-03-17 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202103401QA SG10202103401QA (en) | 2008-03-17 | 2009-03-17 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
SG10201808863UA SG10201808863UA (en) | 2008-03-17 | 2009-03-17 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
Country Status (16)
Country | Link |
---|---|
US (8) | US9534205B2 (de) |
EP (3) | EP2279243B1 (de) |
JP (6) | JP5951254B2 (de) |
KR (1) | KR101679082B1 (de) |
CN (2) | CN102027105B (de) |
AU (1) | AU2009225665B9 (de) |
BR (1) | BRPI0908708A2 (de) |
CA (1) | CA2718904C (de) |
ES (1) | ES2690554T3 (de) |
HK (2) | HK1151559A1 (de) |
IL (1) | IL208144B (de) |
MX (1) | MX2010010165A (de) |
RU (1) | RU2010139426A (de) |
SG (4) | SG188904A1 (de) |
WO (1) | WO2009117439A2 (de) |
ZA (1) | ZA201006683B (de) |
Families Citing this family (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110171185A1 (en) * | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
US7682828B2 (en) | 2003-11-26 | 2010-03-23 | Whitehead Institute For Biomedical Research | Methods for reprogramming somatic cells |
EP1984487B1 (de) | 2005-08-03 | 2022-10-12 | Astellas Institute for Regenerative Medicine | Verbesserte verfahren zur reprogrammierung somatischer tierzellen |
IL286053B2 (en) | 2005-10-18 | 2023-03-01 | Nat Jewish Health | A process for making red blood cells using immortal hematopoietic stem cells and erythropoietin |
US8129187B2 (en) | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
AU2006325975B2 (en) * | 2005-12-13 | 2011-12-08 | Kyoto University | Nuclear reprogramming factor |
US20090227032A1 (en) * | 2005-12-13 | 2009-09-10 | Kyoto University | Nuclear reprogramming factor and induced pluripotent stem cells |
US8278104B2 (en) * | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
EP2626416A3 (de) | 2007-04-07 | 2013-12-18 | The Whitehead Institute for Biomedical Research | Umprogrammierung von somatischen Zellen |
US9213999B2 (en) * | 2007-06-15 | 2015-12-15 | Kyoto University | Providing iPSCs to a customer |
JP2008307007A (ja) * | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
US20140342984A1 (en) * | 2007-10-19 | 2014-11-20 | Robert G. Matheny | Compositions for Regenerating Defective or Absent Myocardium |
AU2009225665B9 (en) | 2008-03-17 | 2015-01-15 | The Scripps Research Institute | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
AU2009233845A1 (en) * | 2008-04-07 | 2009-10-15 | Nupotential, Inc. | Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator |
KR101661940B1 (ko) | 2008-05-02 | 2016-10-04 | 고쿠리츠 다이가쿠 호진 교토 다이가쿠 | 핵 초기화 방법 |
KR20170078862A (ko) | 2008-05-16 | 2017-07-07 | 타이가 바이오테크놀로지스, 인코포레이티드 | 항체 및 그 제조 방법 |
US9497943B2 (en) | 2008-06-13 | 2016-11-22 | Whitehead Institute For Biomedical Research | Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides |
CA2731767C (en) | 2008-07-21 | 2016-12-06 | Taiga Biotechnologies, Inc. | Differentiated anucleated cells and method for preparing the same |
US8298825B1 (en) * | 2008-08-25 | 2012-10-30 | The General Hospital Corporation | TGF-beta receptor inhibitors to enhance direct reprogramming |
EP3916010A1 (de) | 2008-08-28 | 2021-12-01 | Taiga Biotechnologies, Inc. | Modulatoren von myc, verfahren zur verwendung davon und verfahren zur identifizierung von mitteln zur modulierung von myc |
EP2376626A4 (de) | 2008-12-13 | 2012-10-17 | Dna Microarray | MIKROUMGEBUNGSNISCHENTEST FÜR CiPS-SCREENING |
EP3312269A1 (de) | 2008-12-17 | 2018-04-25 | The Scripps Research Institute | Erzeugung und erhaltung von stammzellen |
EP2641911A3 (de) * | 2008-12-23 | 2014-01-01 | Vivoscript, Inc. | Zusammensetzungen und Verfahren zur Neuprogrammierung von Zellen ohne genetische Modifikation |
WO2010115052A2 (en) * | 2009-04-03 | 2010-10-07 | The Mclean Hospital Corporation | Induced pluripotent stem cells |
US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
JP5777113B2 (ja) | 2009-05-29 | 2015-09-09 | 学校法人慶應義塾 | 人工多能性幹細胞のクローンの選択方法 |
JP5751548B2 (ja) * | 2009-08-07 | 2015-07-22 | 国立大学法人京都大学 | イヌiPS細胞及びその製造方法 |
EP3235901B1 (de) * | 2009-10-16 | 2022-12-21 | The Scripps Research Institute | Induzierung pluripotenter zellen |
AU2014250681B2 (en) * | 2009-10-16 | 2016-12-15 | The Scripps Research Institute | Induction of pluripotent cells |
JP2013507974A (ja) | 2009-10-29 | 2013-03-07 | マックマスター ユニバーシティー | 線維芽細胞からの誘導多能性幹細胞および前駆細胞の作製法 |
KR101874463B1 (ko) * | 2009-10-31 | 2018-08-02 | 뉴 월드 레보러토리즈 인코포레이티드. | 세포의 재프로그램화 방법 및 이의 용도 |
KR101775926B1 (ko) * | 2009-11-04 | 2017-09-07 | 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 | 화학 물질을 이용한 에피솜 재프로그래밍 |
US20130189780A1 (en) * | 2009-12-31 | 2013-07-25 | Fate Therapeutics, Inc. | Reprogramming compositions |
US20130059385A1 (en) * | 2010-03-02 | 2013-03-07 | The Scripps Research Institute | Methods of generating pluripotent stem cells |
EP2366432A1 (de) * | 2010-03-16 | 2011-09-21 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Inhibitoren von Glykogensynthasekinase-3 zur Verwendung in Therapieverfahren und damit verwandtes Screeningverfahren |
JP5909482B2 (ja) | 2010-03-31 | 2016-04-26 | ザ スクリプス リサーチ インスティテュート | 細胞の再プログラム |
CN102260646B (zh) * | 2010-05-26 | 2015-09-16 | 北京瑞普晨创科技有限公司 | 一种制备诱导多潜能干细胞的方法,试剂盒及用途 |
EP2580320B1 (de) | 2010-06-14 | 2018-08-01 | The Scripps Research Institute | Neuprogrammierung von zellen für ein neues zellschicksal |
AU2011268056B2 (en) | 2010-06-18 | 2014-04-24 | Cellular Dynamics International, Inc. | Cardiomyocyte medium with dialyzed serum |
WO2012007725A2 (en) * | 2010-07-16 | 2012-01-19 | Plasticell Ltd | Method of reprogramming a cell |
WO2012030854A2 (en) | 2010-09-01 | 2012-03-08 | Whitehead Institute For Biomedical Research | Compositions and methods for modulating emt and uses thereof |
WO2012031288A1 (en) * | 2010-09-03 | 2012-03-08 | United States Of America As Represented By The Department Of Veterans Affairs | Efficient generation of neurally-induced mesenchymal stem cells and applications thereof |
WO2012036299A1 (en) | 2010-09-14 | 2012-03-22 | Kyoto University | Method of efficiently establishing induced pluripotent stem cells |
EP3536337A1 (de) * | 2010-09-22 | 2019-09-11 | The Regents of the University of Colorado, a body corporate | Therapeutische anwendungen von smad7 |
KR101921350B1 (ko) * | 2010-12-17 | 2018-11-22 | 바이오라미나 에이비 | 인간 다능성 줄기세포를 유지하기 위한 시스템 |
AU2011349446C1 (en) * | 2010-12-22 | 2016-01-21 | Fate Therapauetics, Inc. | Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs |
CN103429732B (zh) * | 2010-12-27 | 2015-09-16 | Lsip基金运营联合公司 | iPS细胞及其制造方法 |
WO2012098260A1 (en) * | 2011-01-21 | 2012-07-26 | Axiogenesis Ag | A non-viral system for the generation of induced pluripotent stem (ips) cells |
WO2012151234A2 (en) | 2011-05-02 | 2012-11-08 | Wayne State University | A protein-induced pluripotent cell technology uses thereof |
WO2012166973A1 (en) | 2011-06-01 | 2012-12-06 | Sanford-Burnham Medical Research Institute | Methods for promoting cell reprogramming |
WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
JP6113160B2 (ja) * | 2011-07-19 | 2017-04-12 | ヴィヴォスクリプト,インコーポレイテッド | 軟骨損傷を修復するために遺伝子改変を伴わずに細胞を再プログラミングするための組成物および方法 |
EP2737064B1 (de) | 2011-07-25 | 2017-12-06 | Kyoto University | Verfahren zum screening induzierter pluripotenter stammzellen |
WO2013058403A1 (ja) | 2011-10-21 | 2013-04-25 | 国立大学法人京都大学 | 層流による多能性維持単一分散細胞培養法 |
US20140329317A1 (en) | 2011-11-25 | 2014-11-06 | Kyoto University | Method for culturing pluripotent stem cell |
KR20210134808A (ko) | 2011-12-05 | 2021-11-10 | 팩터 바이오사이언스 인크. | 세포를 형질감염시키는 방법들 및 생성물들 |
US8497124B2 (en) | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
WO2013131000A1 (en) * | 2012-03-01 | 2013-09-06 | Whitehead Institute For Biomedical Research | Emt-inducing transcription factors cooperate with sox9 |
EP2825637A4 (de) * | 2012-03-14 | 2015-12-23 | Childrens Medical Center | Bildbasiertes chemisches screening mit hohem durchsatz in einer zebrafisch-blastomeren-zellkultur |
EP3868387A1 (de) | 2012-07-20 | 2021-08-25 | Taiga Biotechnologies, Inc. | Verbesserte wiederherstellung und autorenkonstitution des hämatopoietischen abteils |
US10357517B1 (en) * | 2012-10-01 | 2019-07-23 | University Of South Florida | Methods of treating epilepsy using neural stem cells that express nanog, SSEA-4, OCT-4, MIR-34B, MIR-34C and MIR-592 |
KR102121086B1 (ko) | 2012-11-01 | 2020-06-09 | 팩터 바이오사이언스 인크. | 세포에서 단백질을 발현시키는 방법들과 생성물들 |
US10130637B2 (en) | 2012-11-02 | 2018-11-20 | Duke University | Inhibition of histone methyltransferase for cardiac reprogramming |
KR102263013B1 (ko) * | 2013-01-09 | 2021-06-10 | 인터내셔날 스템 셀 코포레이션 | 피부 재생을 촉진시키는 소분자 |
US20160002599A1 (en) | 2013-02-08 | 2016-01-07 | Kyoto University | Production methods for megakaryocytes and platelets |
JP6292415B2 (ja) | 2013-03-06 | 2018-03-14 | 国立大学法人京都大学 | 多能性幹細胞の培養システム及び多能性幹細胞の継代方法 |
WO2014138670A1 (en) | 2013-03-08 | 2014-09-12 | The Regents Of The University Of Colorado, A Body Corporate | Ptd-smad7 therapeutics |
US10272115B2 (en) | 2013-03-11 | 2019-04-30 | Taiga Biotechnologies, Inc. | Production and use of red blood cells |
US9365825B2 (en) * | 2013-03-11 | 2016-06-14 | Taiga Biotechnologies, Inc. | Expansion of adult stem cells in vitro |
US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
NZ713219A (en) | 2013-03-14 | 2017-04-28 | Massachusetts Inst Technology | Compositions and methods for epithelial stem cell expansion and culture |
JP6473077B2 (ja) | 2013-03-21 | 2019-02-20 | 国立大学法人京都大学 | 神経分化誘導用の多能性幹細胞 |
US10072242B2 (en) | 2013-03-25 | 2018-09-11 | Foundation For Biomedical Research And Innovation At Kobe | Cell sorting method |
KR20140121317A (ko) * | 2013-04-06 | 2014-10-15 | 서울대학교산학협력단 | 비신경 세포로부터 유도 신경 줄기 세포의 생산 방법 및 이에 의하여 생산되는 유도 신경 줄기 세포 |
CA2909230C (en) | 2013-04-12 | 2021-06-15 | Kyoto University | Method for inducing alveolar epithelial progenitor cells |
WO2014185358A1 (ja) | 2013-05-14 | 2014-11-20 | 国立大学法人京都大学 | 効率的な心筋細胞の誘導方法 |
WO2014192909A1 (ja) | 2013-05-31 | 2014-12-04 | iHeart Japan株式会社 | ハイドロゲルを組み込んだ積層化細胞シート |
BR112015030918A2 (pt) | 2013-06-11 | 2017-12-05 | Astellas Pharma Inc | método para produção de células progenitoras renais, e fármacos contendo células progenitoras renais |
CN104278008B (zh) | 2013-07-12 | 2020-08-21 | 北京宏冠再生医学科技有限公司 | 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途 |
KR101655383B1 (ko) * | 2013-07-27 | 2016-09-08 | 고려대학교 산학협력단 | 소분자 화합물을 포함하는 만능성 줄기세포의 염색체 안정성 유지용 조성물 |
US9796962B2 (en) | 2013-08-07 | 2017-10-24 | Kyoto University | Method for generating pancreatic hormone-producing cells |
EP3042951B1 (de) | 2013-09-05 | 2019-02-20 | Kyoto University | Neues verfahren zur induktion von dopaminproduzierenden neuralen vorläuferzellen |
CN104419683A (zh) * | 2013-09-10 | 2015-03-18 | 中国科学院生物物理研究所 | 制备范可尼贫血症患者自体诱导多能干细胞的方法及其应用 |
WO2015061568A1 (en) * | 2013-10-23 | 2015-04-30 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Reprogramming cardiomyocytes with one transcription factor |
CA3194454A1 (en) | 2013-10-25 | 2015-04-30 | Wayne State University | Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming |
US10100283B2 (en) | 2013-11-01 | 2018-10-16 | Kyoto University | Efficient chondrocyte induction method |
US9512406B2 (en) | 2013-12-20 | 2016-12-06 | The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone | Generating hepatocytes |
US9770489B2 (en) | 2014-01-31 | 2017-09-26 | Factor Bioscience Inc. | Methods and products for nucleic acid production and delivery |
CN104894060B (zh) * | 2014-03-03 | 2018-11-06 | 中国科学院上海生命科学研究院 | 诱导体细胞转分化为神经干细胞的方法及其应用 |
EP3805369A1 (de) | 2014-03-04 | 2021-04-14 | Fate Therapeutics, Inc. | Verbesserte neuprogrammierungsverfahren und zellkulturplattformen |
EP3170901B1 (de) | 2014-07-14 | 2021-06-02 | Chugai Seiyaku Kabushiki Kaisha | Verfahren zur produktion dendritischer zellen aus stammzellen |
US20170211091A1 (en) * | 2014-07-16 | 2017-07-27 | Fundación Pública Andaluza Progreso Y Salud | Methods for generating induced pluripotent stem cells |
US20160030484A1 (en) * | 2014-08-04 | 2016-02-04 | University Of Kansas | Mammalian pluripotent stem cells, methods for their production, and uses thereof |
RU2565548C1 (ru) * | 2014-08-05 | 2015-10-20 | Дмитрий Андреевич Журавлёв | Способ получения плюрипотентных стволовых клеток |
WO2016022930A1 (en) | 2014-08-07 | 2016-02-11 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Reversible stencils for fabricating micro-tissues |
KR102493376B1 (ko) | 2014-09-03 | 2023-01-27 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 청력 손실의 치료를 위해 내이 털세포를 생성하기 위한 조성물, 시스템, 및 방법 |
JP7253692B2 (ja) | 2014-12-26 | 2023-04-07 | 国立大学法人京都大学 | 肝細胞誘導方法 |
WO2016117139A1 (ja) * | 2015-01-20 | 2016-07-28 | タカラバイオ株式会社 | 神経系細胞の製造方法 |
EP3770252A1 (de) | 2015-01-26 | 2021-01-27 | Fate Therapeutics, Inc. | Zellen mit erhöhten immunregulatorischen eigenschaften und verfahren zu deren verwendung und herstellung |
WO2016120493A1 (en) * | 2015-01-30 | 2016-08-04 | Centre National De La Recherche Scientifique (Cnrs) | Reprogramming method for producing induced pluripotent stem cells (ipsc) |
US11241505B2 (en) | 2015-02-13 | 2022-02-08 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
EP3259348A4 (de) | 2015-02-17 | 2018-07-18 | University Health Network | Verfahren zur herstellung und verwendung von sinusknotenartigen schrittmacherkardiomyozyten und herzkammerartigen kardiomyozyten |
JP2016202172A (ja) | 2015-04-16 | 2016-12-08 | 国立大学法人京都大学 | 疑似膵島の製造方法 |
WO2017015320A1 (en) | 2015-07-21 | 2017-01-26 | Children's Medical Center Corporation | Pd-l1 expressing hematopoietic stem cells and uses |
WO2017033863A1 (ja) * | 2015-08-21 | 2017-03-02 | 京都府公立大学法人 | 骨芽細胞及びその調製方法 |
AU2016338680B2 (en) * | 2015-10-16 | 2022-11-17 | Fate Therapeutics, Inc. | Platform for the induction and maintenance of ground state pluripotency |
EP3378933A4 (de) * | 2015-10-21 | 2019-04-03 | Kyoto Prefectural Public University Corporation | Zellenherstellungsverfahren |
CN108779437A (zh) | 2016-01-08 | 2018-11-09 | 麻省理工学院 | 分化的肠内分泌细胞和胰岛素产生细胞的制备 |
KR20180114032A (ko) * | 2016-01-08 | 2018-10-17 | 국립연구개발법인 고쿠리츠간켄큐센터 | 저분자 화합물에 의한 성숙 간세포로부터의 간 줄기/전구세포의 제작 방법 |
KR20180096707A (ko) * | 2016-01-20 | 2018-08-29 | 페이트 세러퓨틱스, 인코포레이티드 | 입양 면역요법에서 면역 세포 조절을 위한 조성물 및 방법 |
EP3405568A4 (de) | 2016-01-20 | 2019-12-04 | Fate Therapeutics, Inc. | Zusammensetzungen und verfahren zur immunzellmodulation bei adoptiven immuntherapien |
US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
US11260130B2 (en) | 2016-03-02 | 2022-03-01 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV |
PT3444334T (pt) | 2016-04-15 | 2021-09-08 | Univ Kyoto | Método para induzir células t cd8 positivas específicas de antigénio |
EP3447130A4 (de) | 2016-04-22 | 2019-11-13 | Kyoto University | Verfahren zur herstellung von dopaminproduzierenden neuralen vorläuferzellen |
CN105943526B (zh) * | 2016-05-18 | 2018-08-14 | 上海交通大学医学院附属上海儿童医学中心 | Pd0325901在维持动脉导管开放中的应用 |
WO2017206837A1 (zh) * | 2016-06-03 | 2017-12-07 | 中国人民解放军军事医学科学院野战输血研究所 | 将消化道来源上皮细胞重编程为内胚层干/祖细胞的小分子化合物组合、重编程方法及应用 |
US20190322643A1 (en) * | 2016-06-29 | 2019-10-24 | Georgia State University Research Foundation, Inc. | Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same |
JP2019528284A (ja) | 2016-08-17 | 2019-10-10 | ファクター バイオサイエンス インコーポレイテッド | 核酸産物およびその投与方法 |
CN109890956A (zh) * | 2016-10-28 | 2019-06-14 | 国立研究开发法人国立癌研究中心 | 人肝前体细胞的制备方法 |
CN113786476A (zh) | 2016-12-02 | 2021-12-14 | 泰加生物工艺学公司 | 纳米颗粒调配物 |
JP7098615B2 (ja) | 2016-12-05 | 2022-07-11 | フェイト セラピューティクス,インコーポレイテッド | 養子免疫療法における免疫細胞調節のための組成物および方法 |
WO2018124118A1 (ja) | 2016-12-27 | 2018-07-05 | 住友化学株式会社 | 人工多能性幹細胞の評価方法及び選抜方法、並びに人工多能性幹細胞の製造方法 |
CN106754655B (zh) * | 2016-12-29 | 2020-06-19 | 赛业(苏州)生物科技有限公司 | 一种动物胚胎培养基 |
US11066419B2 (en) | 2016-12-30 | 2021-07-20 | Frequency Therapeutics, Inc. | 1H-pyrrole-2,5-dione compounds and methods of using same |
EP4053268A3 (de) | 2017-01-20 | 2022-12-07 | Kyoto University | Verfahren zur herstellung von cd8alpha+beta+zytotoxischen t-zellen |
EP3575392A4 (de) | 2017-01-26 | 2020-08-26 | Osaka University | Medium zur induzierung der differenzierung von stammzellen in mesodermale zellen und verfahren zur herstellung mesodermaler zellen |
US11559548B2 (en) | 2017-03-14 | 2023-01-24 | Kyoto University | Method for producing helper T cells from pluripotent stem cells |
CA3064830A1 (en) | 2017-05-25 | 2018-11-29 | Kyoto University | Method for inducing differentiation of intermediate mesodermal cell to renal progenitor cell, and method for inducing differentiation of pluripotent stem cell to renal progenitor cell |
CN111164209A (zh) | 2017-06-19 | 2020-05-15 | 公益财团法人神户医疗产业都市推进机构 | 多能干细胞的分化能力的预测方法和用于该预测方法的试剂 |
US10149898B2 (en) | 2017-08-03 | 2018-12-11 | Taiga Biotechnologies, Inc. | Methods and compositions for the treatment of melanoma |
US20190062711A1 (en) * | 2017-08-25 | 2019-02-28 | So Young Life Sciences Corporation | Use Of Phosphorylated TBeta4 And Other Factors To Generate Human Induced Pluripotent Stem Cells |
WO2019060708A1 (en) | 2017-09-22 | 2019-03-28 | The Children's Medical Center Corporation | TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS |
JP7140400B2 (ja) | 2017-10-17 | 2022-09-21 | 国立大学法人京都大学 | 多能性幹細胞から人工神経筋接合部を得る方法 |
KR101810014B1 (ko) | 2017-10-23 | 2018-01-18 | 차의과학대학교 산학협력단 | 히스톤 데아세틸라제 저해제 및 골 형성 단백질 경로 차단제를 이용한 인간-유래의 체세포로부터 역분화 만능 줄기세포의 제조방법 |
KR101810008B1 (ko) | 2017-10-23 | 2018-01-18 | 차의과학대학교 산학협력단 | 역분화-증진제를 이용한 인간-유래의 체세포로부터 역분화 만능 줄기세포의 제조방법 |
KR101998633B1 (ko) * | 2017-10-31 | 2019-07-11 | 가톨릭관동대학교산학협력단 | 엘립티신의 줄기세포의 연골세포로의 분화 유도 용도 |
CN108624562B (zh) * | 2018-05-18 | 2021-11-02 | 首都医科大学附属北京朝阳医院 | 一种制备肿瘤干细胞的方法及其专用试剂盒 |
KR102158783B1 (ko) * | 2018-06-18 | 2020-09-22 | 한국생명공학연구원 | 세포 리프로그래밍 조성물 및 이를 이용한 유도만능줄기세포의 제조방법 |
EP3822342A4 (de) | 2018-07-13 | 2022-08-03 | Kyoto University | Verfahren zur herstellung von gamma delta t-zellen |
US20210299331A1 (en) | 2018-07-19 | 2021-09-30 | Kyoto University | Pluripotent stem cell-derived plate-shaped cartilage and method for producing the same |
WO2020022261A1 (ja) | 2018-07-23 | 2020-01-30 | 国立大学法人京都大学 | 新規腎前駆細胞マーカーおよびそれを利用した腎前駆細胞の濃縮方法 |
AU2019321641A1 (en) | 2018-08-17 | 2021-04-15 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating Jag-1 |
WO2020037326A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating foxo |
WO2020116606A1 (ja) | 2018-12-06 | 2020-06-11 | キリンホールディングス株式会社 | T細胞又はnk細胞の製造方法、t細胞又はnk細胞の培養用培地、t細胞又はnk細胞の培養方法、未分化t細胞の未分化状態を維持する方法及びt細胞又はnk細胞の増殖促進剤 |
EP3900787A4 (de) | 2018-12-21 | 2022-02-23 | Kyoto University | Lubricin-lokalisiertes knorpelähnliches gewebe, verfahren zur herstellung davon und zusammensetzung damit zur behandlung von gelenkknorpelschäden |
US20220062341A1 (en) | 2018-12-26 | 2022-03-03 | Kirin Holdings Kabushiki Kaisha | Modified tcr and production method therefor |
CA3140384A1 (en) | 2019-05-15 | 2020-11-19 | Ajinomoto Co., Inc. | Method for purifying neural crest cells or corneal epithelial cells |
WO2020235319A1 (ja) | 2019-05-20 | 2020-11-26 | 味の素株式会社 | 軟骨又は骨の前駆細胞の拡大培養方法 |
WO2021015228A1 (ja) * | 2019-07-25 | 2021-01-28 | 富士フイルム株式会社 | 特定の分化細胞の製造方法 |
US10501404B1 (en) | 2019-07-30 | 2019-12-10 | Factor Bioscience Inc. | Cationic lipids and transfection methods |
CN112301052A (zh) * | 2019-08-01 | 2021-02-02 | 浙江霍德生物工程有限公司 | 一种通过体细胞重编程制备诱导多功能干细胞的方法 |
CN115023233A (zh) | 2019-12-12 | 2022-09-06 | 国立大学法人千叶大学 | 包含巨核细胞和血小板的冷冻干燥制剂 |
KR102087084B1 (ko) * | 2020-02-03 | 2020-03-10 | 주식회사 이에이치엘바이오 | 항노화인자를 발현하는 지방유래 줄기세포의 대량 배양방법 |
CN115243724A (zh) | 2020-02-19 | 2022-10-25 | 纳米医疗有限公司 | 可用于治疗癌症的经调配和/或共调配的含有TFGβ拮抗剂前药的脂质体组合物和其方法 |
JP2023516632A (ja) | 2020-02-28 | 2023-04-20 | 武田薬品工業株式会社 | 多能性幹細胞からナチュラルキラー細胞を産生するための方法 |
EP4170020A1 (de) | 2020-06-17 | 2023-04-26 | Kyoto University | Immunkompetente zellen mit chimärem antigenrezeptorexpression |
JP7429294B2 (ja) | 2020-07-13 | 2024-02-07 | 国立大学法人京都大学 | 骨格筋前駆細胞及びその精製方法、筋原性疾患を治療するための組成物、並びに骨格筋前駆細胞を含む細胞群の製造方法 |
JPWO2022019152A1 (de) | 2020-07-20 | 2022-01-27 | ||
EP4202041A1 (de) | 2020-08-18 | 2023-06-28 | Kyoto University | Verfahren zur aufrechterhaltung und amplifikation menschlicher primordialer keimzellen / menschliche primordiale keimzellenähnliche zellen |
JPWO2022196714A1 (de) | 2021-03-17 | 2022-09-22 | ||
AU2022266430A1 (en) | 2021-04-30 | 2023-12-14 | Riken | Cord-like aggregates of retinal pigment epithelial cells, device and production method for producing same, and therapeutic agent comprising said cord-like aggregates |
WO2022255489A1 (ja) | 2021-06-04 | 2022-12-08 | キリンホールディングス株式会社 | 細胞組成物、細胞組成物の製造方法及び細胞組成物を含む医薬組成物 |
CA3222761A1 (en) | 2021-06-10 | 2022-12-15 | Ajinomoto Co., Inc. | Method for producing mesenchymal stem cells |
EP4355861A1 (de) | 2021-06-15 | 2024-04-24 | Takeda Pharmaceutical Company Limited | Verfahren zur herstellung natürlicher killerzellen aus pluripotenten stammzellen |
WO2023283631A2 (en) * | 2021-07-08 | 2023-01-12 | The Broad Institute, Inc. | Methods for differentiating and screening stem cells |
EP4372079A1 (de) | 2021-07-15 | 2024-05-22 | Astellas Pharma Inc. | Pericyt-ähnliche zellen mit expression von vaskulärem endothelwachstumsfaktor (vegf) auf hohem niveau |
JPWO2023286834A1 (de) | 2021-07-15 | 2023-01-19 | ||
WO2023017848A1 (ja) | 2021-08-11 | 2023-02-16 | 国立大学法人京都大学 | 腎間質前駆細胞の製造方法並びにエリスロポエチン産生細胞、およびレニン産生細胞の製造方法 |
WO2023074648A1 (ja) * | 2021-10-25 | 2023-05-04 | 富士フイルム株式会社 | 腸内分泌細胞を製造する方法、多能性幹細胞由来の腸内分泌細胞、培地又は培地キット、およびそれらの利用 |
CN116694551A (zh) * | 2022-02-24 | 2023-09-05 | 清华大学 | 诱导性成熟肝脏细胞及其制备的方法 |
CN114702591B (zh) * | 2022-05-17 | 2022-09-23 | 诺赛联合(北京)生物医学科技有限公司 | 成体细胞衍生的类器官制备技术 |
WO2024078118A1 (en) * | 2022-10-12 | 2024-04-18 | Peking University | Chemical reprogramming and pluripotent stem cells |
JP7461691B1 (ja) | 2023-06-23 | 2024-04-04 | 株式会社アンプリー | 炭酸ガスパック用キット |
Family Cites Families (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR901228A (fr) | 1943-01-16 | 1945-07-20 | Deutsche Edelstahlwerke Ag | Système d'aimant à entrefer annulaire |
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
US5010175A (en) | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
IE66205B1 (en) | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
US5384253A (en) | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
US5702932A (en) | 1992-07-20 | 1997-12-30 | University Of Florida | Microinjection methods to transform arthropods with exogenous DNA |
US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
WO1995003402A1 (en) * | 1993-07-22 | 1995-02-02 | Merck & Co., Inc. | EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL |
US5519134A (en) | 1994-01-11 | 1996-05-21 | Isis Pharmaceuticals, Inc. | Pyrrolidine-containing monomers and oligomers |
US5593853A (en) | 1994-02-09 | 1997-01-14 | Martek Corporation | Generation and screening of synthetic drug libraries |
US5539083A (en) | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
US5656610A (en) | 1994-06-21 | 1997-08-12 | University Of Southern California | Producing a protein in a mammal by injection of a DNA-sequence into the tongue |
US5525735A (en) | 1994-06-22 | 1996-06-11 | Affymax Technologies Nv | Methods for synthesizing diverse collections of pyrrolidine compounds |
US5549974A (en) | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5569588A (en) | 1995-08-09 | 1996-10-29 | The Regents Of The University Of California | Methods for drug screening |
US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
US5780448A (en) | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
GB9807935D0 (en) * | 1998-04-14 | 1998-06-10 | Univ Edinburgh | Lineage specific cells and progenitor cells |
US5945100A (en) | 1996-07-31 | 1999-08-31 | Fbp Corporation | Tumor delivery vehicles |
US5981274A (en) | 1996-09-18 | 1999-11-09 | Tyrrell; D. Lorne J. | Recombinant hepatitis virus vectors |
CA2288639A1 (en) | 1997-05-07 | 1998-11-12 | Pharma Mar, S.A. | Aplidine as an l-type calcium channel enhancer |
WO1998056913A1 (en) | 1997-06-13 | 1998-12-17 | Ludwig Institute For Cancer Research | Smad6 and uses thereof |
US5994624A (en) | 1997-10-20 | 1999-11-30 | Cotton Incorporated | In planta method for the production of transgenic plants |
US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
US20060263382A1 (en) | 1998-06-20 | 2006-11-23 | Richard Hotchkiss | Membrane-permeant peptide complexes for treatment of sepsis |
CA2336220A1 (en) * | 1998-07-24 | 2000-02-03 | The Carnegie Institution Of Washington | Method for maintenance and propagation of germline stem cells using members of the tgf-.beta. family of growth factors |
GB9819912D0 (en) * | 1998-09-11 | 1998-11-04 | Univ Edinburgh | Propagation and/or derivation of embryonic stem cells |
US6696440B1 (en) | 1999-01-07 | 2004-02-24 | Warner-Lambert Company | Treatment of asthma with MEK inhibitors |
US6703420B1 (en) | 1999-03-19 | 2004-03-09 | Bristol-Myers Squibb Pharma Company | Amino-thio-acrylonitriles as MEK inhibitors |
US6730293B1 (en) | 1999-08-24 | 2004-05-04 | Cellgate, Inc. | Compositions and methods for treating inflammatory diseases of the skin |
US20020142457A1 (en) * | 1999-12-28 | 2002-10-03 | Akihiro Umezawa | Cell having the potentiality of differentiation into cardiomyocytes |
EP1438390A4 (de) * | 2001-09-21 | 2005-05-25 | Univ Rochester | Zircadiane kontrolle der selbsterneuerung und differenzierung von stamm-/vorläuferzellen und der zeitlich kontrollierten genexpression |
US7700572B2 (en) | 2001-11-02 | 2010-04-20 | Giuliani International, Ltd. | SMAD7 inhibitors for the treatment of CNS diseases |
US20030204862A1 (en) * | 2002-03-05 | 2003-10-30 | Ralf Kuehn | Inbred embryonic stem-cell derived mice |
GB0210539D0 (en) | 2002-05-08 | 2002-06-19 | Univ Edinburgh | Control of es cell self renewal and lineage specification, and medium therefor |
BR0316238A (pt) | 2002-11-15 | 2005-10-11 | Warner Lambert Co | Quimioterapia de associação compreendendo um inibidor de mek e capecitabina para tratamento de câncer |
US7265138B2 (en) * | 2003-02-10 | 2007-09-04 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
AU2003901099A0 (en) | 2003-03-11 | 2003-03-27 | Es Cell International Pte Ltd. | Methods of inducing differentiation of stem cells |
US20070010008A1 (en) * | 2005-06-29 | 2007-01-11 | Tissuetech, Inc. | Ex vivo expansion of primary animal cells |
WO2005084158A2 (en) | 2003-06-20 | 2005-09-15 | The Regents Of The University Of California | Polypeptide transduction and fusogenic peptides |
CA2540135C (en) | 2003-10-03 | 2012-12-04 | Keiichi Fukuda | Method of inducing the differentiation of stem cells into cardiomyocytes |
GB2407048B (en) | 2003-10-15 | 2007-07-11 | Biotrace Internat Plc | Laboratory apparatus |
WO2005038010A2 (en) | 2003-10-16 | 2005-04-28 | The University Court Of The University Of Edinburgh | Control of es cell self-renewal and lineage specification, and medium therefor |
WO2005049812A1 (en) | 2003-11-19 | 2005-06-02 | Australian Stem Cell Centre Limited | Methods for producing blood products from pluripotent cells in cell culture |
US20070269412A1 (en) | 2003-12-02 | 2007-11-22 | Celavie Biosciences, Llc | Pluripotent cells |
MX2007001772A (es) * | 2004-08-13 | 2007-07-11 | Univ Georgia Res Found | Composiciones y metodos para auto-renovacion y diferenciacion de celulas troncales embrionicas humanas. |
US20080268533A1 (en) * | 2004-08-25 | 2008-10-30 | University Of Georgia Research Foundation, Inc. | Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells |
US20060182724A1 (en) * | 2005-02-15 | 2006-08-17 | Riordan Neil H | Method for expansion of stem cells |
US7601699B2 (en) * | 2005-08-01 | 2009-10-13 | Nupotential, Inc. | Production of reprogrammed cells with restored potential |
WO2007030693A2 (en) | 2005-09-08 | 2007-03-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods for promoting stem cell proliferation and survival |
WO2007056221A2 (en) * | 2005-11-03 | 2007-05-18 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
TW200730623A (en) * | 2005-11-11 | 2007-08-16 | Univ Edinburgh | Reprogramming and genetic modification of cells |
US8217042B2 (en) * | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
US20090227032A1 (en) * | 2005-12-13 | 2009-09-10 | Kyoto University | Nuclear reprogramming factor and induced pluripotent stem cells |
AU2006325975B2 (en) * | 2005-12-13 | 2011-12-08 | Kyoto University | Nuclear reprogramming factor |
JP5024049B2 (ja) | 2005-12-16 | 2012-09-12 | 株式会社明電舎 | 真空コンデンサ |
GB0601538D0 (en) * | 2006-01-26 | 2006-03-08 | Univ Birmingham | Epigenetic analysis |
JPWO2007088651A1 (ja) | 2006-02-01 | 2009-06-25 | 国立大学法人 東京大学 | TGF−βシグナル阻害剤と抗腫瘍剤の組み合せ使用 |
US7541186B2 (en) | 2006-02-22 | 2009-06-02 | University Of Washington | Method of generating human retinal progenitors from embryonic stem cells |
GB0615327D0 (en) | 2006-03-30 | 2006-09-13 | Univ Edinburgh | Culture medium containing kinase inhibitors and uses thereof |
CA2645170A1 (en) * | 2006-03-30 | 2007-10-11 | The University Court Of The University Of Edinburgh | Culture medium containing kinase inhibitors, and uses thereof |
US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
WO2007130474A2 (en) | 2006-05-02 | 2007-11-15 | Wisconsin Alumni Research Foundation | Method of differentiating stem cells into cells of the endoderm and pancreatic lineage |
GB2437737B (en) | 2006-05-04 | 2008-07-09 | Access Products Ltd | Scaffolding |
JP2009542666A (ja) | 2006-06-30 | 2009-12-03 | シェーリング コーポレイション | P53活性を増加させる置換ピペリジンおよびその使用 |
AU2007271964B2 (en) | 2006-07-14 | 2012-01-19 | Novartis Ag | Pyrimidine derivatives as ALK-5 inhibitors |
US20080020014A1 (en) | 2006-07-19 | 2008-01-24 | Paul Consigny | Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders |
GB0622395D0 (en) | 2006-11-09 | 2006-12-20 | Univ Cambridge Tech | Methods relating to pluripotent cells |
US7892830B2 (en) | 2007-01-17 | 2011-02-22 | Wisconsin Alumni Research Foundation | Clonal culture of human pluripotent stem cells |
WO2008088882A2 (en) | 2007-01-19 | 2008-07-24 | The J. David Gladstone Institutes | Methods of generating cardiomyocytes |
WO2008094597A2 (en) | 2007-01-30 | 2008-08-07 | University Of Georgia Research Foundation, Inc. | Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc) |
EP2132225A4 (de) | 2007-02-27 | 2010-06-09 | Procell Therapeutics Inc | Kombinierte anwendung von zellgängigen nanog und oct4 zur erhöhung der selbsterneuerung und unterdrückung der differenzierung von stammzellen |
ES2703592T3 (es) | 2007-03-07 | 2019-03-11 | Mei Pharma Inc | Combinación de agente anticancerígeno de bencimidazol y un segundo agente anticancerígeno |
WO2008126932A2 (en) | 2007-04-09 | 2008-10-23 | Riken | Epigenetical regulation of brain plasticity |
WO2008129554A1 (en) * | 2007-04-18 | 2008-10-30 | Hadasit Medical Research Services & Development Limited | Stem cell-derived retinal pigment epithelial cells |
US8648069B2 (en) * | 2007-06-08 | 2014-02-11 | Abbvie Inc. | 5-substituted indazoles as kinase inhibitors |
JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
CA2691793A1 (en) | 2007-06-29 | 2009-01-08 | Cellular Dynamics International, Inc. | Automated method and apparatus for embryonic stem cell culture |
WO2009032456A2 (en) | 2007-08-01 | 2009-03-12 | Primegen Biotech Llc | Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state |
EP3078738B1 (de) * | 2007-08-31 | 2020-05-20 | Whitehead Institute for Biomedical Research | Wnt-weg-stimulierung bei der umprogrammierung somatischer zellen |
WO2009057831A1 (ja) | 2007-10-31 | 2009-05-07 | Kyoto University | 核初期化方法 |
JP4604076B2 (ja) * | 2007-11-07 | 2010-12-22 | 国立大学法人静岡大学 | 燃料電池用電解質膜 |
EP2227540A4 (de) | 2007-11-29 | 2011-11-02 | Children S Hospital Of Orange County | Entdifferenzierung menschlicher zellen |
EP2224940A1 (de) | 2007-11-30 | 2010-09-08 | Cytomatrix PTY LTD | Verfahren zur induktion von pluripotenz mit oct4-protein |
US20110190729A1 (en) | 2007-11-30 | 2011-08-04 | Cytomatrix Pty Ltd | Methods of inducing pluripotency involving sox2 protein |
WO2009082184A2 (en) | 2007-12-26 | 2009-07-02 | Posdata Co., Ltd. | Method for determining spurious and wireless communication system applying that method |
AU2009225665B9 (en) * | 2008-03-17 | 2015-01-15 | The Scripps Research Institute | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
US8298825B1 (en) * | 2008-08-25 | 2012-10-30 | The General Hospital Corporation | TGF-beta receptor inhibitors to enhance direct reprogramming |
EP3312269A1 (de) | 2008-12-17 | 2018-04-25 | The Scripps Research Institute | Erzeugung und erhaltung von stammzellen |
US20120122212A1 (en) * | 2009-03-06 | 2012-05-17 | Marica Grskovic | Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells |
JP5777113B2 (ja) * | 2009-05-29 | 2015-09-09 | 学校法人慶應義塾 | 人工多能性幹細胞のクローンの選択方法 |
CN102625837B (zh) * | 2009-08-07 | 2015-01-14 | 国立大学法人京都大学 | 有效建立诱导的多能干细胞的方法 |
EP3235901B1 (de) | 2009-10-16 | 2022-12-21 | The Scripps Research Institute | Induzierung pluripotenter zellen |
CN102844428B (zh) | 2010-03-05 | 2015-09-02 | 德克萨斯心脏研究所 | Ets2和mesp1由成纤维细胞生成心脏祖细胞 |
JP5909482B2 (ja) | 2010-03-31 | 2016-04-26 | ザ スクリプス リサーチ インスティテュート | 細胞の再プログラム |
TWI552751B (zh) | 2011-06-20 | 2016-10-11 | H 朗德貝克公司 | 投予4-((1r,3s)-6-氯-3-苯基-二氫茚-1-基)-1,2,2-三甲基-哌及其鹽用於治療精神***症的方法 |
US9166832B1 (en) | 2013-10-04 | 2015-10-20 | Altera Corporation | Methods and apparatus for decision feedback equalization adaptation |
-
2009
- 2009-03-17 AU AU2009225665A patent/AU2009225665B9/en active Active
- 2009-03-17 CA CA2718904A patent/CA2718904C/en active Active
- 2009-03-17 BR BRPI0908708A patent/BRPI0908708A2/pt not_active IP Right Cessation
- 2009-03-17 SG SG2013019211A patent/SG188904A1/en unknown
- 2009-03-17 SG SG10201607710UA patent/SG10201607710UA/en unknown
- 2009-03-17 RU RU2010139426/10A patent/RU2010139426A/ru not_active Application Discontinuation
- 2009-03-17 KR KR1020107023172A patent/KR101679082B1/ko active IP Right Grant
- 2009-03-17 EP EP09721278.1A patent/EP2279243B1/de active Active
- 2009-03-17 SG SG10202103401QA patent/SG10202103401QA/en unknown
- 2009-03-17 ES ES15177122.7T patent/ES2690554T3/es active Active
- 2009-03-17 CN CN200980117686.XA patent/CN102027105B/zh active Active
- 2009-03-17 JP JP2011500906A patent/JP5951254B2/ja active Active
- 2009-03-17 SG SG10201808863UA patent/SG10201808863UA/en unknown
- 2009-03-17 EP EP18185585.9A patent/EP3409762A1/de active Pending
- 2009-03-17 CN CN201510084514.4A patent/CN104694570B/zh active Active
- 2009-03-17 WO PCT/US2009/037429 patent/WO2009117439A2/en active Application Filing
- 2009-03-17 US US12/933,391 patent/US9534205B2/en active Active
- 2009-03-17 EP EP15177122.7A patent/EP2955222B1/de active Active
- 2009-03-17 MX MX2010010165A patent/MX2010010165A/es not_active Application Discontinuation
-
2010
- 2010-03-12 US US12/723,063 patent/US9068170B2/en active Active
- 2010-04-02 US US12/753,386 patent/US9394524B2/en active Active
- 2010-09-14 IL IL208144A patent/IL208144B/en active IP Right Grant
- 2010-09-17 ZA ZA2010/06683A patent/ZA201006683B/en unknown
-
2011
- 2011-06-08 HK HK11105755.1A patent/HK1151559A1/zh unknown
-
2013
- 2013-03-14 US US13/831,289 patent/US9540615B2/en active Active
-
2015
- 2015-01-28 JP JP2015013821A patent/JP2015119714A/ja active Pending
- 2015-10-16 HK HK15110187.5A patent/HK1209457A1/xx unknown
-
2016
- 2016-06-10 US US15/179,657 patent/US9771563B2/en active Active
- 2016-08-02 JP JP2016151681A patent/JP6321733B2/ja active Active
- 2016-11-30 US US15/365,823 patent/US9926533B2/en active Active
-
2017
- 2017-08-23 US US15/684,851 patent/US20180002671A1/en not_active Abandoned
-
2018
- 2018-02-08 US US15/892,312 patent/US20180171303A1/en active Pending
- 2018-04-05 JP JP2018072807A patent/JP6899792B2/ja active Active
-
2021
- 2021-06-15 JP JP2021099098A patent/JP7286710B2/ja active Active
-
2023
- 2023-05-24 JP JP2023085020A patent/JP2023101613A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1209457A1 (en) | Combined chemical and genetic approaches for generation of induced pluripotent stem cells | |
HK1216905A1 (zh) | 多能幹細胞的分化 | |
ZA201606403B (en) | Pluripotent stem cell culture on micro-carriers | |
GB2458863B (en) | Improved culture of stem cells | |
SG10201402428WA (en) | Method of efficiently establishing induced pluripotent stem cells | |
EP2315829A4 (de) | Induzierte pluripotente stammzellen | |
SG10201608797WA (en) | Method of efficiently establishing induced pluripotent stem cells | |
PL2046946T3 (pl) | Hodowla pluripotencjalnych komórek macierzystych | |
EP2414510A4 (de) | Induzierte pluripotente stammzellen | |
PL2356227T3 (pl) | Kapsułkowanie komórek trzustki pochodzących z ludzkich pluripotencjalnych komórek macierzystych | |
EP2487236A4 (de) | Kultursubstrat für menschliche pluripotente stammzellen und verwendung davon | |
HK1199469A1 (en) | Generation and maintenance of stem cells | |
IL211764A0 (en) | Markers of induced pluripotent stem cells | |
SG10201500674YA (en) | Pluripotent stem cells | |
ZA201000715B (en) | Single pluripotent stem cell culture | |
GB0814249D0 (en) | Uses of mesenchymal stem cells | |
EP2494032A4 (de) | Erzeugung induzierter pluripotenter stammzellen und vorläuferzellen aus fibroblasten | |
ZA201008392B (en) | Treatment of pluripotent cells | |
EP2440652A4 (de) | Verfahren zur kultivierung von stammzellen und vorläuferzellen | |
GB0622394D0 (en) | Differentiation of pluripotent cells | |
EP2499241A4 (de) | Verfahren zur produktion neuraler stammzellen | |
IL217063A0 (en) | Generation of induced pluripotent stem cells from cord blood | |
EP2513297A4 (de) | Materialien und verfahren zur erzeugung pluripotenter stammzellen | |
IL218111A0 (en) | Enhanced efficiency of induced pluripotent stem cell generation from human somatic cells | |
EP2352817A4 (de) | Stammzellen aus der riechschleimhaut und ihre verwendung |